ATE533859T1 - MARKER FÜR NIERENTRANSPLANTATABSTOßUNG UND NIERENSCHÄDEN - Google Patents

MARKER FÜR NIERENTRANSPLANTATABSTOßUNG UND NIERENSCHÄDEN

Info

Publication number
ATE533859T1
ATE533859T1 AT07253514T AT07253514T ATE533859T1 AT E533859 T1 ATE533859 T1 AT E533859T1 AT 07253514 T AT07253514 T AT 07253514T AT 07253514 T AT07253514 T AT 07253514T AT E533859 T1 ATE533859 T1 AT E533859T1
Authority
AT
Austria
Prior art keywords
kidney
markers
transplant rejection
damage
renal
Prior art date
Application number
AT07253514T
Other languages
English (en)
Inventor
Stefan Kienle
Richard Joubert
Original Assignee
Electrophoretics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Electrophoretics Ltd filed Critical Electrophoretics Ltd
Application granted granted Critical
Publication of ATE533859T1 publication Critical patent/ATE533859T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • G01N2800/245Transplantation related diseases, e.g. graft versus host disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07253514T 2006-09-05 2007-09-05 MARKER FÜR NIERENTRANSPLANTATABSTOßUNG UND NIERENSCHÄDEN ATE533859T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0617429.6A GB0617429D0 (en) 2006-09-05 2006-09-05 Markers of renal transplant rejection and renal damage

Publications (1)

Publication Number Publication Date
ATE533859T1 true ATE533859T1 (de) 2011-12-15

Family

ID=37232368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07253514T ATE533859T1 (de) 2006-09-05 2007-09-05 MARKER FÜR NIERENTRANSPLANTATABSTOßUNG UND NIERENSCHÄDEN

Country Status (6)

Country Link
US (2) US8021895B2 (de)
EP (2) EP1905846B1 (de)
AT (1) ATE533859T1 (de)
CA (1) CA2600168A1 (de)
ES (1) ES2379430T3 (de)
GB (1) GB0617429D0 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2153234A2 (de) * 2007-05-11 2010-02-17 The Institutes for Pharmaceutical Discovery, LLC Verfahren zur frühdiagnose einer nierenerkrankung
CA2720862A1 (en) * 2008-04-10 2009-10-15 The University Of British Columbia Methods of diagnosing chronic cardiac allograft rejection
US20110189680A1 (en) * 2008-05-30 2011-08-04 The University Of British Columbia Methods of Diagnosing Rejection of a Kidney Allograft Using Genomic or Proteomic Expression Profiling
NZ610356A (en) * 2008-08-28 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2735590A1 (en) * 2008-08-29 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010048347A2 (en) * 2008-10-21 2010-04-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ607703A (en) 2008-10-21 2014-09-26 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102264230B (zh) 2008-11-10 2014-12-10 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
MX2011005379A (es) * 2008-11-22 2011-06-09 Astute Medical Inc Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
US9229010B2 (en) 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2011008323A (es) * 2009-02-06 2011-09-21 Astute Medical Inc Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
US20110065599A1 (en) * 2009-08-07 2011-03-17 Rules-Based Medicine, Inc. Methods and Devices for Detecting Kidney Damage
CA2770393A1 (en) * 2009-08-07 2011-02-10 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201290106A1 (ru) * 2009-09-18 2012-12-28 Астьют Медикал, Инк. Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности
NZ630277A (en) * 2009-09-21 2015-02-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2488661B1 (de) * 2009-10-14 2014-12-24 Oberbauer, Rainer Prüfung auf Risiko einer akuten Nierenverletzung
EP2496942B1 (de) 2009-11-07 2017-03-22 Astute Medical, Inc. Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
JP5763098B2 (ja) 2009-12-20 2015-08-12 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
PT2666872T (pt) 2010-02-05 2016-07-08 Astute Medical Inc Processos e composições para o diagnóstico e o prognóstico de lesões renais e de insuficiência renal
EP3070474A3 (de) 2010-02-26 2016-12-07 Astute Medical, Inc. Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
IN2012MN02812A (de) 2010-06-23 2015-05-22 Astute Medical Inc
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
ES2734494T3 (es) 2011-12-08 2019-12-10 Astute Medical Inc Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal
CA2880793A1 (en) * 2012-08-03 2014-02-06 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
TR201807542T4 (tr) 2013-01-17 2018-06-21 Astute Medical Inc Böbrek hasarı ve böbrek yetmezliği teşhisi ve prognozuna yönelik metotlar ve bileşimler.
US10300108B2 (en) 2013-12-03 2019-05-28 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US10451636B2 (en) 2014-04-09 2019-10-22 The Regents Of The University Of California Protein biomarkers for immune assessment and prediction of transplant rejection
US9764078B2 (en) * 2014-06-06 2017-09-19 The University Of Manchester Extracorporeal removal of anti-IQCJ antibodies from blood
US11243202B2 (en) 2015-04-09 2022-02-08 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US10989716B2 (en) 2015-05-01 2021-04-27 The University Of British Columbia Biomarkers for the detection of acute rejection in heart transplantation
EP3465201A4 (de) 2016-06-06 2020-08-26 Astute Medical, Inc. Verwaltung von akuter nierenverletzung mit insulinähnlichem wachstumsfaktorbindendem protein 7 und gewebehemmer der metalloproteinase 2
CN113092769A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液补体c4-a及其多肽片段在过敏性疾病中的应用
KR102314642B1 (ko) * 2020-04-17 2021-10-20 재단법인 아산사회복지재단 파브리 병 진단용 바이오 마커 및 이의 용도
EP4397976A1 (de) * 2023-01-09 2024-07-10 x-kidney diagnostics GmbH Biomarker zur präklinischen und/oder frühen erkennung und/oder diagnose von nierenerkrankungen
WO2025183579A1 (en) 2024-02-29 2025-09-04 Ramalhete Lus Manuel Pires Prognostic method for determining a probability of allograft rejection

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4731326A (en) * 1984-06-04 1988-03-15 Ortho Diagnostic Systems Inc. Disease diagnosis by detection of shed normal tissue antigens
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5591721A (en) 1994-10-25 1997-01-07 Hybridon, Inc. Method of down-regulating gene expression
WO1996037777A1 (en) * 1995-05-23 1996-11-28 Nelson Randall W Mass spectrometric immunoassay
AU9510498A (en) * 1997-09-26 1999-04-12 University Of Washington Methods and compositions for diagnosing renal pathologies
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
WO2001025791A2 (en) 1999-10-07 2001-04-12 Ciphergen Biosystems, Inc. Prostate cancer marker proteins
US20030003588A1 (en) * 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
DK1426764T3 (da) * 2001-08-17 2011-06-27 Fujirebio Kk Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme
DE602004022150D1 (de) * 2003-03-27 2009-09-03 Childrens Hosp Medical Center Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung

Also Published As

Publication number Publication date
US20120065095A1 (en) 2012-03-15
US20080153092A1 (en) 2008-06-26
EP2333116A3 (de) 2011-10-12
US8741580B2 (en) 2014-06-03
GB0617429D0 (en) 2006-10-18
ES2379430T3 (es) 2012-04-26
EP2333116A2 (de) 2011-06-15
EP2333116B1 (de) 2015-05-06
EP1905846B1 (de) 2011-11-16
US8021895B2 (en) 2011-09-20
EP1905846A3 (de) 2008-07-09
CA2600168A1 (en) 2008-03-05
EP1905846A2 (de) 2008-04-02

Similar Documents

Publication Publication Date Title
ATE533859T1 (de) MARKER FÜR NIERENTRANSPLANTATABSTOßUNG UND NIERENSCHÄDEN
EP1848739A4 (de) Adamts-7 als biomarker für epithelkrebs
IL189263B (en) Identification and engineering of antibodies with variant fc regions and methods of using same
DK1974210T3 (da) Fremgangsmåde til diagnosticering af polycystisk nyresygdom
DE602006017335D1 (de) Sensoranordnung für sattelkupplung
EP2021989A4 (de) Geführtes navigationssystem
DE602005001107D1 (de) Techniken für Mikrokanalkühlung
DE602006010967D1 (de) Reise-Verknüpfungsidentifikationssystem
IL225386A (en) Method for diagnosis of cancer by detecting an ereg protein
DE602006009605D1 (de) Verfahren zur Bearbeitung von Turbinenelementen
EP2358907A4 (de) Mit autismus assoziierte genetische marker
DK2024747T3 (da) Anvendelse af protein SATB2 som prognotisk markør for colerectal cancer
DK2021792T3 (da) Opløste protein-artritmarkører
BRPI0714209A2 (pt) Induzidor de morte celular
ATE479699T1 (de) Neue markierungsstrategien für den empfindlichen nachweis von analyten
DE602006011229D1 (de) System zur Stromsymmetrierung
FI20055198A0 (fi) Visualisointitekniikka biologista infomaatiota varten
DE602006013109D1 (de) Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs
DE112007003222A5 (de) Prognostische Marker für die Klassifizierung von kolorektalen Karzinomen basierend auf Expressionsprofilen von biologischen Proben
DE602006015887D1 (de) Wiederaufnamesystem für Luftschiffe
ITBO20060366A1 (it) Centro di lavoro per la lavorazione di pezzi in legno od assimilabili.
ATE465147T1 (de) Anthrachinonderivate als markierstoffe für flüssigkeiten
DE502004006249D1 (de) Informationssystem für Fortbewegungsmittel
DE602006000859D1 (de) Werkzeug zur Bearbeitung von Rohren
DE602006018146D1 (de) Markierungsring für Brieftauben